2-(((5S)-2-Oxo-3-(4-(3-oxo-4-morpholinyl)phenyl)-5-oxazolidinyl)methyl)-1H-isoindole-1,3(2H)-dione

cas: 446292-08-6 — zobacz wszystkie produkty o tym numerze CAS, także pod innymi nazwami

2-(((5S)-2-Oxo-3-(4-(3-oxo-4-morpholinyl)phenyl)-5-oxazolidinyl)methyl)-1H-isoindole-1,3(2H)-dione (CAS 446292-08-6) to odczynnik chemiczny dostępny w ofercie Chemat. Dostępne opakowania: 25mg, 100mg. Oferty producentów: Mikromol.

• 2D
• 3D

2-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]isoindole-1,3-dione (CAS 446292-08-6) to związek chemiczny o wzorze sumarycznym C22H19N3O6 i masie molowej 421.4 g/mol. Nazwa systematyczna IUPAC: 2-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]isoindole-1,3-dione. InChIKey: KUQNYAUTIWQAKY-MRXNPFEDSA-N.

Dane identyfikacyjne

Wzór sumaryczny	C22H19N3O6
Masa molowa	421.4 g/mol
Nazwa IUPAC	2-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]isoindole-1,3-dione
InChIKey	KUQNYAUTIWQAKY-MRXNPFEDSA-N
SMILES	C1COCC(=O)N1C2=CC=C(C=C2)N3C[C@@H](OC3=O)CN4C(=O)C5=CC=CC=C5C4=O

Dane obliczone przez PubChem (NCBI)

Synonimy: Rivaroxaban EP Impurity G, 4-[4-[(5S)-5-Phthalimidomethyl-2-oxo-3-oxazolidinyl]phenyl]-3-morpholinone, KUQNYAUTIWQAKY-MRXNPFEDSA-N, Rivaroxaban Impurity D, Rivaroxaban Intermediates II, Rivaroxaban Related Compound G, Rivaroxaban Related Compound G [USP-RS], (S)-2-((2-Oxo-3-(4-(3-oxomorph, RIVAROXABAN IMPURITY G [EP IMPURITY]

Powiązane formy tego związku

2-[[(5R)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]isoindole-1,3-dione C₂₂H₁₉N₃O₆

2-[[2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]isoindole-1,3-dione C₂₂H₁₉N₃O₆

2-[[(5S)-2-oxo-3-[2,3,5,6-tetradeuterio-4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]isoindole-1,3-dione C₂₂H₁₉N₃O₆

Izomery (ten sam wzór sumaryczny)

(6R,14aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-6,8,14,14a-tetrahydro-3H-pyrazino[1,2-d][1,4]benzodiazonine-1,4,7,13-tetrone C₂₂H₁₉N₃O₆

(6R,14aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-6,8,14,14a-tetrahydro-3H-pyrazino[1,2-d][1,4]benzodiazonine-1,4,7,13-tetrone C₂₂H₁₉N₃O₆

(8'aR)-6'-(1,3-benzodioxol-5-yl)-2'-methylspiro[1H-3,1-benzoxazine-4,7'-3,6,8,8a-tetrahydropyrrolo[1,2-a]pyrazine]-1',2,4'-trione C₂₂H₁₉N₃O₆

(10R,11R,17R)-17-(1,3-benzodioxol-5-yl)-1-hydroxy-13-methyl-2,13,16-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-3,5,7-triene-9,12,15-trione C₂₂H₁₉N₃O₆

(11R,17R)-17-(1,3-benzodioxol-5-yl)-1-hydroxy-13-methyl-8,13,16-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6-triene-9,12,15-trione C₂₂H₁₉N₃O₆

6'-(1,3-benzodioxol-5-yl)-2'-methylspiro[1H-3,1-benzoxazine-4,7'-3,6,8,8a-tetrahydropyrrolo[1,2-a]pyrazine]-1',2,4'-trione C₂₂H₁₉N₃O₆

(11R,17R)-17-(1,3-benzodioxol-5-yl)-1-hydroxy-13-methyl-2,13,16-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-3,5,7-triene-9,12,15-trione C₂₂H₁₉N₃O₆

(5S)-14-(aminomethyl)-5-ethyl-5-hydroxy-7,18,20-trioxa-11,24-diazahexacyclo[11.11.0.02,11.04,9.015,23.017,21]tetracosa-1(24),2,4(9),13,15,17(21),22-heptaene-6,10-dione C₂₂H₁₉N₃O₆

[1-[(9-ethylcarbazol-3-yl)amino]-1-oxopropan-2-yl] 5-nitrofuran-2-carboxylate C₂₂H₁₉N₃O₆